ISDA

Entry Detail

PDB ID:

4DO3

Keywords:

HYDROLASE/HYDROLASE INHIBITOR

Title:

Structure of FAAH with a non-steroidal anti-inflammatory drug

Biological Source:

Source Organism:

Rattus norvegicus

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2012-02-09

Release Date:

2013-01-23

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.25 Å

R-Value Free:

0.19

R-Value Work:

0.16

R-Value Observed:

0.16

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Fatty-acid amide hydrolase 1
Chain IDs:A, B
Chain Length:571
Number of Molecules:2
Biological Source:Rattus norvegicus

UniProt ID:P97612 Pfam ID:PF01425 EC:3.5.1.4

Ligand Molecules

0LA

OHO

Primary Citation

A Binding Site for Nonsteroidal Anti-inflammatory Drugs in Fatty Acid Amide Hydrolase.

Bertolacci, L, Romeo, E, Veronesi, M, Magotti, P, Albani, C, Dionisi, M, Lambruschini, C, Scarpelli, R, Cavalli, A, De Vivo, M, Piomelli, D, Garau, G.Show

J.Am.Chem.Soc. 135 22 25 (2013)

PMID: 23240907 DOI: 10.1021/ja308733u

Abstact

In addition to inhibiting the cyclooxygenase (COX)-mediated biosynthesis of prostanoids, various widely used nonsteroidal anti-inflammatory drugs (NSAIDs) enhance endocannabinoid signaling by blocking the anandamide-degrading membrane enzyme fatty acid amide hydrolase (FAAH). The X-ray structure of FAAH in complex with the NSAID carprofen, along with site-directed mutagenesis, enzyme activity assays, and NMR analysis, has revealed the molecular details of this interaction, providing information that may guide the design of dual FAAH-COX inhibitors with superior analgesic efficacy.

Legend

Protein

Chemical

Disease

Primary Citation of related structures